Related Experiment Videos
[Comparison between two types of pertussis vaccines]
Summary
Industrial methods yield 4-7 times more pertussis vaccine than lab methods. Both vaccines are non-toxic, but industrial vaccines show reduced histamine sensitization in mice, ensuring reproducible quality.
Area of Science:
- Microbiology
- Vaccine Development
- Immunology
Background:
- Pertussis (whooping cough) remains a significant public health concern, necessitating effective vaccine production methods.
- Current vaccine production involves laboratory-scale stationary cultures, which may limit yield and reproducibility.
- Optimizing cultivation techniques is crucial for meeting global demand for pertussis vaccines.
Purpose of the Study:
- To compare the efficacy and characteristics of pertussis vaccines produced via laboratory and industrial cultivation methods.
- To evaluate the yield, toxicity, and histamine sensitization of vaccines from different production scales.
- To assess the reproducibility of industrial vaccine production.
Main Methods:
- Laboratory cultivation of *Bordetella pertussis* on Hornibrook medium in stationary culture.
- Industrial cultivation of *B. pertussis* in homogenous culture using B-2 medium in a fermentor.
- Assessment of vaccine yield (org. x 10(9)/ml), non-toxicity (mouse weight gain), and histamine sensitization in mice.
Main Results:
- Industrial cultivation yielded 4 to 7 times higher *B. pertussis* concentrations compared to laboratory methods.
- Both laboratory and industrially produced vaccines demonstrated non-toxicity in mice.
- Vaccines produced via industrial fermentation exhibited lower histamine sensitization in mice than those from stationary flask cultures.
Conclusions:
- Industrial-scale fermentation offers a significantly higher yield for pertussis vaccine production.
- Industrial methods produce vaccines with improved immunological profiles (less histamine sensitization) and high reproducibility.
- Fermentor-based production is a viable and superior alternative for large-scale, quality-controlled pertussis vaccine manufacturing.